Interventional Oncology & Embolization

The Embold Detachable Coil System is a portfolio of three fully retractable coils built to maximize procedural flexibility and reliability. Used for arterial and venous embolization in the peripheral vasculature of adults, the Embold coils take coiling simplicity to a new level, offering multi-catheter compatibility to lessen procedure time and complexity; a nitinol delivery system that’s resistant to kinking and premature detachment; handle-free detachment to reduce procedure steps and cost; and occlusion power for more certainty.

The Obsidio Conformable Embolic is used to embolize blood vessels and stop blood from flowing to a specific area. Through a process called shear thinning, it starts as an injectable soft solid, flows as a liquid when force is applied, and returns to a soft solid to occlude the vessel. It is the first and only conformable embolic indicated to treat bleeds and tumors in the peripheral vasculature.

TheraSphere is a radioembolization treatment for patients diagnosed with primary liver cancer and metastatic liver cancer.* A targeted therapy, TheraSphere consists of millions of glass microspheres containing radioactive yttrium-90 that are delivered into the hepatic artery to selectively target and destroy tumor cells while minimizing distribution and impact to normal tissue. The radioactive microspheres continue to deliver radiation to the tumor over the course of several weeks after treatment.

The Intera 3000 Hepatic Artery Infusion (HAI) Pump is a liver-directed treatment option for people with tumors in the liver that are caused by metastatic colorectal cancer (mCRC) and intrahepatic cholangiocarcinoma (iCCA). The pump is implanted in the abdomen and connected to a catheter placed in the hepatic artery.  Unlike systemic chemotherapy, HAI therapy limits potential side effects throughout the body by delivering therapy directly to the liver. HAI therapy can help shrink metastatic liver tumors to help patients achieve treatment goals, including control of liver disease and conversion to eligibility for surgical resection, which may not have been possible with systemic chemotherapy alone. 

The ICEfx^TM Cryoablation System is a next generation ablation system that is used to freeze and destroy tissues of kidney, lung and bone tumors. It features a compact design and interface that gives physicians predictable and seamless therapy delivery.  This minimally invasive treatment is an effective option for tumor control and pain palliation that requires only a short hospital stay with rapid recovery.